Beigene (BGNE)

Trade BGNE now with
9/21/2020 7:06:01 AM Leap Therapeutics And BeiGene Says First Patient Dosed In DisTinGuish Study
7/27/2020 9:21:44 AM BeiGene Says Priority Review Granted To NDA Of Pamiparib In Ovarian Cancer In China
7/17/2020 9:03:02 AM BeiGene Reports Acceptance Of NDA Of Pamiparib In Ovarian Cancer In China
7/1/2020 7:09:49 AM BeiGene Appoints Angus Grant As Chief Business Executive
6/19/2020 12:34:10 AM BeiGene Announces Acceptance Of SNDA For Tislelizumab In Combination With Chemotherapy In China
6/18/2020 7:33:51 AM BeiGene Reports EMA Acceptance Of Its Marketing Authorization Application For BRUKINSA
6/3/2020 7:18:29 AM BeiGene Says BTK Inhibitor BRUKINSA Has Received Approval From NMPA In Two Indications
5/29/2020 8:28:46 AM BeiGene Presents Phase 3 Data On Tislelizumab Combined With Chemotherapy
4/20/2020 4:16:46 PM BeiGene Says China Accepted SNDA Of Anti-PD-1 Antibody Tislelizumab Plus Chemotherapy For First-line Treatment Of NSCLC
3/25/2020 9:05:57 AM BeiGene: NMPA Suspended Importation, Sales And Use Of ABRAXANE In China
3/2/2020 4:13:11 PM BeiGene Q4 Loss/share $0.49 Vs. Loss $0.35 Year Ago
1/21/2020 7:03:11 AM BeiGene: Phase 3 Clinical Trial Of Tislelizumab Meets Primary Endpoint Of Progression-Free Survival At Interim Analysis
1/3/2020 8:56:50 AM Leap Therapeutics, BeiGene Announce Exclusive Option & License Agreement For DKN-01
1/2/2020 8:42:29 AM BeiGene Says Global Strategic Oncology Collaboration With Amgen Effective